🚀 VC round data is live in beta, check it out!
Aqua Bio Technology Valuation Multiples
Discover revenue and EBITDA valuation multiples for Aqua Bio Technology and similar public comparables like Pharmena, Mycodern, BioRegenx, Arctic Bioscience and more.
Aqua Bio Technology Overview
About Aqua Bio Technology
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
Founded
2000
HQ
Employees
2
Website
Financials (FY)
EV
$22M
Aqua Bio Technology Financials
Aqua Bio Technology reported last fiscal year revenue of $11M and negative EBITDA of ($34M).
In the same fiscal year, Aqua Bio Technology generated $215K in gross profit, ($34M) in EBITDA losses, and had net loss of ($36M).
Aqua Bio Technology P&L
In the most recent fiscal year, Aqua Bio Technology reported revenue of $11M and EBITDA of ($34M).
Aqua Bio Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $11M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $215K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($34M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (295%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (115%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($36M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (317%) | XXX | XXX | XXX |
| Net Debt | — | — | $14M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Aqua Bio Technology Stock Performance
Aqua Bio Technology has current market cap of $11M, and enterprise value of $22M.
Market Cap Evolution
Aqua Bio Technology's stock price is $0.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22M | $11M | 9.2% | XXX | XXX | XXX | $-2.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAqua Bio Technology Valuation Multiples
Aqua Bio Technology trades at 2.0x EV/Revenue multiple, and (0.7x) EV/EBITDA.
Aqua Bio Technology Financial Valuation Multiples
As of April 18, 2026, Aqua Bio Technology has market cap of $11M and EV of $22M.
Equity research analysts estimate Aqua Bio Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aqua Bio Technology has a P/E ratio of (0.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $11M | XXX | $11M | XXX | XXX | XXX |
| EV (current) | $22M | XXX | $22M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.7x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 103.2x | XXX | XXX | XXX |
| P/E | — | XXX | (0.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aqua Bio Technology Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Aqua Bio Technology Margins & Growth Rates
Aqua Bio Technology's revenue in the last fiscal year grew by 479%.
Aqua Bio Technology's revenue per employee in the last FY averaged $5.7M, while opex per employee averaged $6.7M for the same period.
Aqua Bio Technology Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 479% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (295%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 2381% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $5.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $6.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 40% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 117% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Aqua Bio Technology Public Comps
See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Aqua Bio Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharmena | XXX | XXX | XXX | XXX | XXX | XXX |
| Mycodern | XXX | XXX | XXX | XXX | XXX | XXX |
| BioRegenx | XXX | XXX | XXX | XXX | XXX | XXX |
| Arctic Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Simris Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aqua Bio Technology M&A Activity
Aqua Bio Technology acquired XXX companies to date.
Last acquisition by Aqua Bio Technology was on XXXXXXXX, XXXXX. Aqua Bio Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Aqua Bio Technology
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAqua Bio Technology Investment Activity
Aqua Bio Technology invested in XXX companies to date.
Aqua Bio Technology made its latest investment on XXXXXXXX, XXXXX. Aqua Bio Technology invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Aqua Bio Technology
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aqua Bio Technology
| When was Aqua Bio Technology founded? | Aqua Bio Technology was founded in 2000. |
| Where is Aqua Bio Technology headquartered? | Aqua Bio Technology is headquartered in Norway. |
| How many employees does Aqua Bio Technology have? | As of today, Aqua Bio Technology has over 2 employees. |
| Is Aqua Bio Technology publicly listed? | Yes, Aqua Bio Technology is a public company listed on Oslo Børs. |
| What is the stock symbol of Aqua Bio Technology? | Aqua Bio Technology trades under ABTEC ticker. |
| When did Aqua Bio Technology go public? | Aqua Bio Technology went public in 2008. |
| Who are competitors of Aqua Bio Technology? | Aqua Bio Technology main competitors are Pharmena, Mycodern, BioRegenx, Arctic Bioscience. |
| What is the current market cap of Aqua Bio Technology? | Aqua Bio Technology's current market cap is $11M. |
| What is the current revenue of Aqua Bio Technology? | Aqua Bio Technology's last fiscal year revenue is $11M. |
| What is the current EV/Revenue multiple of Aqua Bio Technology? | Current revenue multiple of Aqua Bio Technology is 2.0x. |
| Is Aqua Bio Technology profitable? | No, Aqua Bio Technology is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.